Argentina's first public brachytherapy unit hits medical technology development mark:
This article was originally published in Clinica
Executive Summary
Argentina's public health system has installed its first brachytherapy unit. The equipment was acquired at a cost of Peso1.16m ($370,000) and installed at the national oncology institute Angel Roffo, part of the Buenos Aires National University (UBA), in the capital. The acquisition is being branded not only as a direct improvement in cancer care through better access to innovative technologies, but is also significant as evidence of the ongoing improvements in the public healthcare system generally, following the economic difficulties of recent years.
You may also be interested in...
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.